ValuationViz

TVTX fund manager activity

Travere Therapeutics, Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q4 2020 to Q2 2026.

Q4 2025

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementTrimmed33,996$1,298,9870.00%Feb 9, 2026
Joel Greenblatt - Gotham Asset ManagementAdded55,984$2,139,1490.01%Feb 17, 2026

Q3 2025

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementTrimmed39,341$940,2490.00%Nov 12, 2025
Joel Greenblatt - Gotham Asset ManagementNew27,743$663,0580.00%Nov 14, 2025

Newer quarters · Older quarters